Our findings highlight the role of FXR in hepatocytes in the pathogenesis of NASH and demonstrate the anti-fibrotic effect of OCA in a unique murine model of NASH with obesity and insulin resistance. This evidence concerns the gene NR1H4 and obesity due to melanocortin 4 receptor deficiency.